Organization Overview
Historical Acquisition Tree
Alternative names
Key: Roche (60) Acquired (18)
alectinib (alecensa) (2015 NDA)
amdinocillin (coactin) (1984 NDA)
amitriptyline (elavil) (1976)
beta carotene (solatene) (1975 NDA)
biotin (1947)
bumetanide (bumex) (NDA)
capecitabine (xeloda) (1998 NDA)
carprofen (1987 NDA)
ceftriaxone (rocephin) (1984 NDA)
chlordiazepoxide (librium) (1966)
chlorprothixene (taractan) (1962 NDA)
clidinium (quarzan) (1966 NDA)
clonazepam (klonopin) (1975 NDA)
cyanocobalamin (berocca) (1947 NDA)
diazepam (valium) (1963 NDA)
doxepin (sinequan) (1969 NDA)
enfuvirtide (fuzeon) (2003 NDA)
entrectinib (Rozlytrek) (2019 NDA)
ergocalciferol (drisdol) (1947)
estrogens, esterified (menrium component estrogens, esterified) (1966 NDA)
etretinate (tegison) (1986 NDA)
flumazenil (mazicon ) (1991 NDA)
flunisolide (nasalide) (1984)
flurazepam (dalmane) (1970 NDA)
folic acid (1947)
ganciclovir (cytovene) (1989 NDA)
granisetron (kytril) (1993 NDA)
ibandronate (boniva) (2003 NDA)
interferon alpha-2a (roferon-a) (1988 NDA)
interferon alpha-2b (Intron-A) (2002)
iofetamine (Spectamine) (1988 NDA)
isotretinoin (Accutane) (1982 NDA)
kappadione (1941 NDA)
ketorolac (acuvail) (1989)
levallorphan (lorfan) (1955 NDA)
levodopa (larodopa) (1970 NDA)
lidocaine (xylocaine) (1984)
mefloquine (lariam) (1989 NDA)
menadiol (synkavite) (1942 NDA)
methoxy polyethylene glycol-epoetin beta (Mircera) (2007 NDA)
methyprylon (noludar) (NDA)
mibefradil (Posicor) (NDA)
midazolam (versed) (1985 NDA)
mycophenolate (CellCept) (1995 NDA)
naproxen (naprosyn) (1976 NDA)
nicardipine (cardene) (NDA)
nicotinamide (1947)
nifedipine (procardia) (NDA)
nitroprusside (nipride) (1974 NDA)
ocrelizumab (ocrevus) (2017 NDA)
orlistat (xenical) (1999 NDA)
oseltamivir (tamiflu) (1999 NDA)
panthenol (1947)
phenazopyridine (gantanol) (1987 NDA)
phytonadione (konakion) (1955 NDA)
polatuzumab vedotin (Polivy) (2019 NDA)
pyridoxine (NDA)
pyrimethamine (daraprim) (1981)
ribavirin (virazole) (2002)
riboflavin (1947)
rimantadine (flumadine) (1993 NDA)
saquinavir (invirase) (1995 NDA)
sulfadoxine (1981)
sulfamethoxazole (gantanol) (1961 NDA)
sulfisoxazole (gantrisin) (1953 NDA)
thiamine (1947)
ticlopidine (ticlid) (1991 NDA)
tocilizumab (actemra) (2010 NDA)
torsemide (demadex) (1993)
trimethaphan (arfonad) (1954 NDA)
trimethoprim (1980)
valganciclovir (Valcyte) (2001 NDA)
vemurafenib (zelboraf) (2011 NDA)
vitamin a (1947)
vitamin c (1947)
vitamin e (1947)
zalcitabine (hivid) (1992 NDA)
Key: Roche (41) Acquired (109)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (3 trials)
abiraterone (zytiga) (6 trials)
acetaminophen (tylenol) (13 trials)
acetazolamide (diamox) (1 trial)
adalimumab (humira) (8 trials)
adefovir dipivoxil (hepsera) (5 trials)
alemtuzumab (campath) (4 trials)
alendronic acid (fosamax) (2 trials)
alteplase (Activase) (21 trials)
amantadine (symmetrel) (4 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (6 trials)
atazanavir (reyataz) (5 trials)
atezolizumab (Tecentriq) (323 trials)
azacitidine (vidaza) (13 trials)
baloxavir marboxil (xofluza) (6 trials)
basiliximab (Simulect) (2 trials)
bendamustine (treanda) (35 trials)
betamethasone (celestone) (4 trials)
bevacizumab (avastin) (548 trials)
bnt162b2 (Comirnaty) (1 trial)
boceprevir (victrelis) (2 trials)
budesonide (rhinocort) (3 trials)
calcipotriene (dovonex) (2 trials)
canrenone (Contaren) (1 trial)
capecitabine (xeloda) (203 trials)
carboplatin (paraplatin) (165 trials)
ceftazidime (fortaz) (1 trial)
ceftriaxone (rocephin) (3 trials)
certolizumab pegol (cimzia) (1 trial)
chlorambucil (Leukeran) (13 trials)
cyclophosphamide (cytoxan) (130 trials)
cyclosporine (sandimmune) (23 trials)
daclizumab (Zenapax) (14 trials)
darbepoetin alfa (aranesp) (12 trials)
darunavir (prezista) (2 trials)
delavirdine (rescriptor) (3 trials)
diltiazem (cardizem) (1 trial)
diphenhydramine (benadryl) (16 trials)
docetaxel (taxotere) (136 trials)
dornase alfa (pulmozyme) (13 trials)
doxorubicin (Doxil) (88 trials)
efalizumab (Raptiva) (23 trials)
efavirenz (sustiva) (6 trials)
emicizumab (Hemlibra) (18 trials)
enfuvirtide (fuzeon) (22 trials)
entecavir (baraclude) (9 trials)
enzalutamide (xtandi) (7 trials)
erlotinib (tarceva) (197 trials)
estradiol (progynon depot) (1 trial)
etanercept (enbrel) (3 trials)
etoposide (vepesid) (40 trials)
everolimus (zortress) (22 trials)
faricimab (Vabysmo) (12 trials)
Filgrastim (neupogen) (8 trials)
fludarabine (fludara) (34 trials)
fluorouracil (efudex) (109 trials)
fluticasone (cutivate) (3 trials)
formoterol (foradil) (3 trials)
fosamprenavir (lexiva) (2 trials)
ganciclovir (cytovene) (26 trials)
gemcitabine (gemzar) (118 trials)
icosapent ethyl (vascepa) (2 trials)
indinavir (crixivan) (2 trials)
infliximab (remicade) (3 trials)
interferon alfacon-1 (Infergen) (3 trials)
interferon alpha-2b (Intron-A) (154 trials)
irinotecan (Camptosar) (76 trials)
isosorbide (isordil) (2 trials)
keyhole limpet hemocyanin (3 trials)
lamivudine (epivir) (10 trials)
letrozole (femara) (22 trials)
lopinavir (Kaletra) (9 trials)
methoxy polyethylene glycol-epoetin beta (Mircera) (67 trials)
methylprednisolone (medrol) (36 trials)
metoprolol (lopressor) (1 trial)
mrna-1273 (Spikevax) (1 trial)
mycophenolate (CellCept) (76 trials)
naltrexone (revia) (80 trials)
nelfinavir (viracept) (7 trials)
nevirapine (viramune) (1 trial)
obinutuzumab (gazyva) (110 trials)
ocrelizumab (ocrevus) (46 trials)
olaparib (lynparza) (7 trials)
omalizumab (xolair) (48 trials)
oseltamivir (tamiflu) (30 trials)
oxaliplatin (eloxatin) (127 trials)
paclitaxel (taxol) (196 trials)
pemetrexed (alimta) (49 trials)
pertuzumab (perjeta) (90 trials)
pioglitazone (actos) (7 trials)
prednisolone (hydeltra) (3 trials)
prednisone (meticorten) (104 trials)
ranibizumab (lucentis) (120 trials)
ribavirin (virazole) (95 trials)
risdiplam (Evrysdi) (13 trials)
risedronate (actonel) (3 trials)
ritonavir (Norvir) (46 trials)
rituximab (rituxan) (283 trials)
saquinavir (invirase) (31 trials)
sevelamer (renagel) (2 trials)
sirolimus (rapamune) (15 trials)
sitagliptin (januvia) (17 trials)
somatropin (protropin) (19 trials)
sucroferric oxyhydroxide (Venofer) (1 trial)
tacrolimus (prograf) (19 trials)
tenecteplase (tnkase) (12 trials)
theophylline (synophylate) (1 trial)
thymalfasin (zadaxin) (1 trial)
tocilizumab (actemra) (188 trials)
trastuzumab (herceptin) (176 trials)
trastuzumab emtansine (kadcyla) (51 trials)
triamcinolone (kenalog) (7 trials)
valganciclovir (Valcyte) (24 trials)
vemurafenib (zelboraf) (67 trials)
venetoclax (venclexta) (73 trials)
vincristine (oncovin) (41 trials)
vinorelbine (navelbine) (30 trials)
warfarin (coumadin) (4 trials)
Key: Roche (64) Acquired (90)
acetylsalicylic acid (aspirin) (6 trials)
acitretin (soriatane) (1 trial)
aflibercept (zaltrap) (11 trials)
aldesleukin (Proleukin) (3 trials)
alectinib (alecensa) (32 trials)
anastrozole (arimidex) (9 trials)
atomoxetine (strattera) (1 trial)
autologous hematopoietic stem cells (3 trials)
azathioprine (imuran) (12 trials)
bacille calmette-guerin (2 trials)
bleomycin (blenoxane) (3 trials)
bortezomib (velcade) (12 trials)
cabazitaxel (jevtana kit) (1 trial)
cabozantinib (cometriq) (9 trials)
candesartan (atacand) (1 trial)
cetuximab (erbitux) (26 trials)
cladribine (leustatin) (3 trials)
clonidine (catapres) (1 trial)
clopidogrel (plavix) (3 trials)
clozapine (clozaril) (1 trial)
coagulation factor viia (recombinant) (NovoSevenRT) (1 trial)
cobimetinib (cotellic) (67 trials)
crizotinib (xalkori) (6 trials)
cytarabine (cytosar-u) (16 trials)
delandistrogene moxeparvovec (2 trials)
desloratadine (clarinex) (2 trials)
dexchlorpheniramine maleate (polaramine) (1 trial)
durvalumab (imfinzi) (2 trials)
eculizumab (Soliris) (2 trials)
emtricitabine (emtriva) (4 trials)
enoxaparin (lovenox) (1 trial)
entrectinib (Rozlytrek) (18 trials)
epirubicin (ellence) (26 trials)
erythromycin (ilosone) (2 trials)
ethinyl estradiol (Estinyl) (3 trials)
exemestane (aromasin) (4 trials)
fenofibrate (fenoglide) (1 trial)
ferric carboxymaltose (Injectafer) (1 trial)
fingolimod (gilenya) (1 trial)
florbetapir (Amyvid) (2 trials)
fulvestrant (faslodex) (21 trials)
fusidic acid (Fucidin) (1 trial)
gemtuzumab ozogamicin (mylotarg) (1 trial)
hepatitis b vaccine (recombinant) (Recombivax) (1 trial)
hydroxychloroquine (plaquenil) (6 trials)
hydroxyurea (hydrea) (1 trial)
inactivated influenza vaccine (1 trial)
insulin glargine (toujeo) (3 trials)
insulin human (humulin) (2 trials)
interferon alpha-2a (roferon-a) (1 trial)
interferon beta-1b (betaseron) (5 trials)
interferon gamma-1b (actimmune) (18 trials)
ixabepilone (ixempra) (5 trials)
leflunomide (arava) (5 trials)
lenalidomide (revlimid) (23 trials)
lenvatinib (lenvima) (2 trials)
liraglutide (victoza) (2 trials)
lurbinectedin (Zepzelca) (1 trial)
mitomycin (mutamycin) (3 trials)
mitoxantrone (novantrone) (6 trials)
montelukast (singulair) (1 trial)
mosunetuzumab (Lunsumio) (19 trials)
multi-valent pneumococcal conjugate vaccine (1 trial)
neostigmine (bloxiverz) (1 trial)
ofatumumab (arzerra) (1 trial)
palbociclib (ibrance) (14 trials)
palmitoylethanolamide (1 trial)
panitumumab (vectibix) (7 trials)
pegylated-interferon (2 trials)
pembrolizumab (keytruda) (6 trials)
polatuzumab vedotin (Polivy) (25 trials)
procarbazine (matulane) (1 trial)
recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)
regorafenib (stivarga) (5 trials)
remdesivir (Veklury) (1 trial)
rucaparib (rubraca) (12 trials)
salmeterol (serevent) (1 trial)
sargramostim (leukine) (11 trials)
satralizumab (Enspryng) (5 trials)
sorafenib (nexavar) (9 trials)
sulfasalazine (azulfidine) (3 trials)
tamoxifen (nolvadex) (5 trials)
telmisartan (micardis) (1 trial)
temozolomide (temodar) (35 trials)
temsirolimus (torisel) (7 trials)
tenofovir (viread) (10 trials)
teriflunomide (aubagio) (2 trials)
topotecan (hycamtin) (10 trials)
urokinase (kinlytic) (1 trial)
vandetanib (caprelsa) (1 trial)
vindesine (Eldisine) (1 trial)
voretigene neparvovec (Luxturna) (3 trials)
Key: Roche (117) Acquired (161)
abemaciclib (verzenio) (6 trials)
acalabrutinib (calquence) (3 trials)
acetylcysteine (mucomyst) (1 trial)
allogeneic gm-csf-secreting breast cancer vaccine (1 trial)
allogeneic pancreatic islet cells (1 trial)
allogeneic stem cells (1 trial)
allopurinol (zyloprim) (1 trial)
aminolevulinic acid (levulan) (1 trial)
amphotericin b (fungizone) (1 trial)
amprenavir (agenerase) (1 trial)
atorvastatin (lipitor) (2 trials)
axicabtagene ciloleucel (Yescarta) (1 trial)
azithromycin (zithromax) (1 trial)
belinostat (beleodaq) (1 trial)
bexarotene (targretin) (3 trials)
bicalutamide (casodex) (3 trials)
bosutinib (bosulif) (2 trials)
buserelin (receptal) (1 trial)
carfilzomib (kyprolis) (2 trials)
cedazuridine (Inqovi) (1 trial)
citalopram (celexa) (2 trials)
clindamycin (cleocin) (1 trial)
copanlisib (aliqopa) (1 trial)
cyanocobalamin (berocca) (2 trials)
dabrafenib (tafinlar) (1 trial)
daratumumab (darzalex) (8 trials)
dasatinib (sprycel) (4 trials)
daunorubicin (cerubidine) (3 trials)
decitabine (dacogen) (3 trials)
doxycycline (vibramycin) (1 trial)
enfortumab vedotin (Padcev) (1 trial)
erdafitinib (Balversa) (1 trial)
escitalopram (lexapro) (4 trials)
fexofenadine (allegra) (2 trials)
fluconazole (diflucan) (2 trials)
flucytosine (ancobon) (1 trial)
fludeoxyglucose f-18 (1 trial)
fluoxetine (prozac) (2 trials)
galantamine (reminyl) (1 trial)
goserelin (zoladex) (5 trials)
hemopoietic stem cell (2 trials)
hyaluronidase (human recombinant) (Hylenex) (7 trials)
hydrocortisone (solu-cortef) (1 trial)
ibalizumab-uiyk (trogarzo) (1 trial)
ibritumomab tiuxetan (Zevalin) (1 trial)
ibrutinib (imbruvica) (11 trials)
immune globulin (human) (Gamastan) (4 trials)
ipilimumab (yervoy) (6 trials)
Isatuximab (Sarclisa) (2 trials)
itraconazole (sporanox) (12 trials)
ladiratuzumab vedotin (1 trial)
leuprolide (lupron) (5 trials)
levocetirizine (xyzal) (1 trial)
levoleucovorin (fusilev) (3 trials)
linagliptin (tradjenta) (3 trials)
loratadine (claritin) (1 trial)